Sudeep Pharma IPO
Sudeep Pharma Limited
Minimum investment
Sudeep Pharma IPO Details
Bidding date
21 Nov - 25 Nov 2025
Price range
₹563 - ₹593
Minimum quantity
25
Minimum investment
₹14,075
Issue size
₹895 Cr.
IPO doc (link)
RHP docs
Listing exchange
NSE/BSE
Sudeep Pharma IPO Dates & Timeline
Sudeep Pharma IPO Subscription Status
Category | Subscription |
|---|---|
Qualified Institutional Buyers | 118.68x |
Retail Individual Investor | - |
Non-Institutional Investor | 21.64x |
Others | - |
Total | - |
About Sudeep Pharma IPO: Company Overview
Sudeep Pharma Limited, incorporated in 1989, is a leading manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients. The company serves customers across more than 100 countries, supported by six manufacturing facilities with a total installed capacity of 50,000 MT.
Its product portfolio includes calcium, iron, zinc, magnesium, sodium, and potassium mineral salts, along with specialty ingredients and triturates. Sudeep Pharma supplies over 200 products to global clients in the pharmaceutical, food, and nutrition industries.
The company has strong in-house R&D capabilities, equipped with advanced labs and pilot-scale facilities focused on innovation in mineral salts and excipients. As of December 31, 2024, the company employed 704 permanent employees.
Strengths & Risks of Sudeep Pharma IPO
Market Leadership in Pharma Excipients: Sudeep Pharma holds a strong leadership position in the pharmaceutical excipients and mineral-based ingredient segment, operating in an industry with high entry barriers and strict regulatory requirements.
Diversified Global Customer Base: The company serves clients across more than 100 countries, maintaining long-term relationships with major pharmaceutical, food, and nutrition brands. This global reach reduces dependency on any single market.
Advanced and Compliant Manufacturing Facilities: Its six manufacturing units are equipped with modern technology and adhere to regulatory standards, ensuring consistent product quality and scalable operations.
Strong Research and Development Capabilities: Sudeep Pharma has dedicated R&D labs and pilot-scale facilities focused on innovation in mineral salts, excipients, and specialty ingredients, enabling continuous product development.
Consistent Financial Growth: The company has demonstrated stable financial performance with healthy profitability. Strong EBITDA margins and growing net worth reflect a solid financial foundation.
Dependence on Global Pharma and Nutrition Sectors: A slowdown in the pharmaceutical, food, or nutrition industries may directly impact demand for the company’s products and overall revenue growth.
Raw Material Price Volatility: The company relies on key mineral-based raw materials, which may experience price fluctuations. This can affect cost structures and margins if not managed effectively.
High Regulatory Dependence: Operating in a heavily regulated sector requires continuous compliance. Any failure to meet regulatory standards can lead to operational disruptions or penalties.
Premium Valuation: The IPO is priced at a higher valuation, with a post-issue P/E of 53.55x. This may be considered expensive when compared to industry peers.
Exposure to Foreign Exchange Movements: With exports to 100+ countries, the company is exposed to currency risks. Fluctuations in foreign exchange rates may impact profitability.
Sudeep Pharma Financials: Revenue, Profit & EBITDA
N/A
N/A
N/A
How to Apply for Sudeep Pharma IPO: Step-by-Step Guide
- Research the IPO:Review the prospectus and company details.
- Open accounts:Ensure you have a demat and trading account.
- Check dates:Note the IPO opening and closing dates.
- Apply online:Log in to your brokerage account and complete the IPO application form.
- Make payment:Pay through your linked bank account.
- Submit application:Confirm and submit your application.
- Track status:Monitor the allotment status and check for shares in your demat account upon listing.
FAQs: Sudeep Pharma IPO
